Found 224 matching trials
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself. N/A A retrospective study of de-identified (to preserve patient privacy) patien...
Show More Learn More & Join Trial
To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer N/A This is a multi-center biomarkers study aiming to prospectively collect bio...
Show More Location
Hospital Santo Stefano
Learn More & Join Trial
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma. PHASE2 This is a Phase 1/2 study evaluating the safety and anti-tumor activity of ...
Show More Location
Northwestern Medical Faculty Foundation
Learn More & Join Trial
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study NA This study is looking at outcomes in people with advanced cancers who have ...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma PHASE1 Our hypothesis is that treating relapsed or refractory multiple myeloma wit...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. N/A The purpose of this research study is to collect samples of blood and stool...
Show More Location
Cancer Care Specialists of Illinois
Learn More & Join Trial
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer PHASE1 The main purpose of this research study is to learn whether the investigati...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer PHASE2 This phase II trial studies the side effects and how well palbociclib and l...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer PHASE1 This study adopts multicenter/randomized trial design. It plans to enroll p...
Show More Location
Multiple Locations
Learn More & Join Trial